HK:0950 Stock Latest News
Company AnnouncementsLee’s Pharm licenses next-generation PARP1 cancer drug OC-3 for Greater China and Southeast Asia1M ago0950
Company AnnouncementsLee’s Pharmaceutical Delivers Strong Interim Profit Growth on Higher-Margin Drug Mix2M ago0950
Company AnnouncementsLee’s Pharmaceutical Declares Interim Cash Dividend for First Half of 20262M ago0950
Company AnnouncementsLee’s Pharmaceutical forecasts higher interim profit on stronger margins and product mix2M ago0950
Company AnnouncementsLee’s Pharmaceutical Sets Board Meeting to Review 2026 Interim Results and Dividend2M ago0950
Company AnnouncementsLee’s Pharm Wins NMPA Nod to Trial First In-House ADC ZK24013M ago0950Company AnnouncementsLee’s Pharm Licenses Interferon Alpha-2b to Ashlins for Markets Outside Greater China3M ago0950
- Company AnnouncementsLee’s Pharm Wins Gates Foundation Funding for Infant Respiratory Drug Push5M ago0950
Company AnnouncementsLee’s Pharmaceutical Wins Strong Shareholder Backing for Dividend, Board and Share Mandates at AGM5M ago0950
Company AnnouncementsLee’s Pharma commits RMB25m to connected biotech partnership fund5M ago0950- Company AnnouncementsLee’s Pharmaceutical Sets 2026 AGM to Approve Results, Dividend and Capital Mandates6M ago0950
Company AnnouncementsLee’s Pharmaceutical Declares Final Dividend for 20257M ago0950Company AnnouncementsLee’s Pharmaceutical posts flat profit on higher costs, trims final dividend7M ago0950
Company AnnouncementsLee’s Pharm Wins China Approval for Intrarosa, Bolstering Women’s Health Portfolio7M ago0950
- Company AnnouncementsLee’s Pharmaceutical Sets March 2026 Board Meeting to Review 2025 Results7M ago0950
Company AnnouncementsLee’s Pharm Wins FDA Clearance for U.S. ADASUVE Manufacturing Shift9M ago0950- Company AnnouncementsLee’s Pharma Adds Financial Detail to Discloseable Asset Acquisition10M ago0950
Company AnnouncementsLee’s Pharmaceutical Mourns Death of Senior Business Development Director Michele Dalla Libera10M ago0950
Company AnnouncementsLee’s Pharmaceutical Acquires Alexza Business Assets for $15 Million10M ago0950Company AnnouncementsLee’s Pharmaceutical Advances Pain Management with Inhaled Fentanyl Study1y ago0950
Company AnnouncementsLee’s Pharmaceutical Advances AU409 Study in Hepatocellular Carcinoma1y ago0950
